HomeMy WebLinkAbout2025-12-Resolution-Purdue Pharam LP Ballot-08/18/2025 CITY OF SANGER,TEXAS
RESOLUTION NO. 2025-12
A RESOLUTION OF THE CITY COUNCIL OF THE CITY OF SANGER, TEXAS,
APPROVING AND AUTHORIZING THE CITY MANAGER TO EXECUTE AND
SUBMIT THE BALLOT INDICATING ACCEPTANCE OF THE THIRTEENTH
AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF PURDUE
PHARMA L.P. AND ITS AFFILIATED DEBTORS AND AUTHORIZING THE
SUBMISSION THEREOF IN THE FORM OF AN E-BALLOT; AND PROVIDING AN
EFFECTIVE DATE.
WHEREAS, the City of Sanger, Texas (the "City") has received notice that a solicitation
agent,on behalf of Purdue Pharma L.P.,its general partner Purdue Pharma,Inc.,and Purdue Pharma's
wholly owned direct and indirect subsidiaries,as debtors and debtors in possession,is soliciting votes
to accept or reject the Thirteenth Amended Joint Chapter 11 Plan of Reorganization of Purdue
Pharma L.P. and Its Affiliated Debtors,dated March 19,2025 (the"Plan"); and
WHEREAS,the City can accept or reject the Plan by adopting and submitting an E-Ballot
on or before September 30, 2025, at 4:00 p.m. (prevailing Eastern Time), attached hereto and
incorporated herein by this reference as Exhibit"A" (the"Ballot Form"); and
WHEREAS, the City Council of the City of Sanger, Texas finds there is a substantial
need for participation in the Plan and supports acceptance of the Plan and finds it in the public
interest to participate in voting on such Plan through the Ballot Form.
NOW,THEREFORE,BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY
OF SANGER, TEXAS,THAT:
SECTION 1. The City Council of the City of Sanger, Texas hereby approves the Thirteenth
Amended Joint Chapter 11 Plan of Reorganization of Purdue Pharma L.P. and Its Affiliated Debtors,
dated March 19, 2025 (the "Plan") and approves and adopts the E-Ballot therefor indicating
acceptance of the Plan.
SECTION 2. The City Manager is hereby authorized on behalf of the City to execute, sign, and
submit or cause to be submitted said Ballot Form using the City's Unique E-Ballot ID assigned
therein,attached hereto and incorporated herein by this reference as Exhibit"A"to Purdue Pharma
Ballot Processing do Kroll Restructuring Administration LLC online at
https://restructuring.ra.kroll.com/purduepharma on or before September 30, 2025 at 4:00 p.m.
(prevailing Eastern Time).
Resolution—Purdue Pharma L.P.
Page 1 of 3
SECTION 3. This Resolution shall become effective immediately upon passage.
PASSED AND APPROVED THIS 18th DAY OF AUGUST,2025.
\\,O tSAAG///'
.F APPROVED:
_ . IPA(
•
Thomas Muir,Mayor
ATTEST: '
///, TE X 1\9 \\\
D maw.),jay
Kell Edwa s, City Secretary
APPROVED AS TO FORM:
Victoria Thomas, Special Counsel
Resolution—Purdue Pharma L.P.
Page 2 of 3
Exhibit A
(Purdue Bankruptcy Ballot Form)
4911-5737-3016,v 1
Resolution—Purdue Pharma L P
Page 3 of 3
89428-26
CLASS 4 BALLOT
PLEASE COMPLETE THE FOLLOWING:
Item 1. Amount of Class 4 Claims. Please note that each Claim in Class 4 has been allowed in
the amount of$1.00 for voting purposes only, and not for purposes of ultimate"Allowance" of a
Claim, distribution of value under the Plan or for any other purpose. For the avoidance of doubt,
the $1.00 amount at which a Claim has been allowed for voting purposes does not impact the
payment that a Holder of a Class 4 Claim may receive.
Claims Amount: $1.00
Item 2. Vote on the Plan. The undersigned Holder of Class 4 Claims hereby votes to (check only
one box):
g ACCEPT(I.E.,VOTE IN FAVOR OF)the Plan
O REJECT(I.E.,VOTE AGAINST) the Plan
Item 3. Acknowledgments and Certification. By signing this Ballot, the undersigned certifies
and/or acknowledges that:
(a) either the undersigned is: (i) the Holder of the Class 4 Claims being voted;
or (ii) an authorized signatory for a person or entity that is a Holder of the
Class 4 Claims being voted, and, in either case, has the full power and
authority to vote to accept or reject the Plan with respect to the Claims
identified in Item 1 above;
(b) the undersigned has been provided with a copy of the Disclosure Statement,
including the Plan and all other exhibits thereto, the Disclosure Statement
& Solicitation Procedures Order without exhibits and a Confirmation
Hearing Notice;
(c) the solicitation of votes is subject to all terms and conditions set forth in the
Plan, Disclosure Statement & Solicitation Procedures Order and the
procedures for the solicitation of votes to accept or reject the Plan contained
therein;
(d) the undersigned has cast the same vote with respect to all of its Class 4
Claims; and
(e) no other Ballots with respect to the amount of the Class 4 Claims identified
in Item 1 above have been cast or, if any other Ballots have been cast with
respect to such Claims,then any such earlier Ballots are hereby revoked.
9
Voter ID: 43161 192364904288377
89428-26
:4Y
Name of Claimant: rc rr-of Sanger, Texas
Signature:
Name of Signatory JOHN NOBLITT
(if different than Claimant):
If authorized by Agent, Title of Agent: CITY OF SANGER, CITY MANAGER
Street Address: 502 ELM STREET
Street Address:
(continued)
City, State,Zip Code: SANGER, TEXAS 76266
Telephone Number: 940-458-7930
Email Address: CITYMANAGER@SANGERTEXAS.ORG
Date Completed:
I 5
10 111111111111111111011
Voter ID: 43161 192364904288377
UNITED STATES BANKRUPTCY COURT
SOUTHERN DISTRICT OF NEW YORK
In re:
PURDUE PHARMA L.P., et al.,1
Debtors.
)
)
)
)
)
)
)
Chapter 11
Case No. 19-23649 (SHL)
(Jointly Administered)
BALLOT FOR VOTING TO ACCEPT OR REJECT
THE THIRTEENTH AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION
OF PURDUE PHARMA L.P. AND ITS AFFILIATED DEBTORS
CLASS 4: NON-FEDERAL DOMESTIC GOVERNMENTAL CLAIMS
Please read and follow the enclosed instructions carefully before completing the ballot. This
ballot is being sent to you to solicit your vote on the Debtors’ Plan of Reorganization.
THIS BALLOT MUST BE COMPLETED, EXECUTED AND RETURNED SO AS TO BE
ACTUALLY RECEIVED BY KROLL RESTRUCTURING ADMINISTRATION LLC
(“KROLL” OR THE “SOLICITATION AGENT”) BY 4:00 P.M. (PREVAILING
EASTERN TIME) ON SEPTEMBER 30, 2025 (THE “VOTING DEADLINE”).
The Solicitation Agent, on behalf of Purdue Pharma L.P. (“Purdue Pharma”), its general
partner Purdue Pharma Inc., and Purdue Pharma’s wholly owned direct and indirect subsidiaries,
as debtors and debtors in possession (collectively, the “Debtors”), is soliciting votes to accept or
reject the Thirteenth Amended Joint Chapter 11 Plan of Reorganization of Purdue Pharma L.P.
and Its Affiliated Debtors, dated March 19, 2025 [D.I. 7306] (together with all schedules and
exhibits thereto, and as may be modified, amended or supplemented from time to time, the “Plan”2)
from the Holders of certain Impaired Claims against the Debtors.
You are receiving this ballot (the “Ballot”) because our records indicate that you have
asserted a Claim against the Debtors as of May 12, 2025 (the “Voting Record Date”). Your Claim
1 The Debtors in these cases, along with the last four digits of each Debtor’s registration number in the applicable
jurisdiction, are as follows: Purdue Pharma L.P. (7484), Purdue Pharma Inc. (7486), Purdue Transdermal
Technologies L.P. (1868), Purdue Pharma Manufacturing L.P. (3821), Purdue Pharmaceuticals L.P. (0034), Imbrium
Therapeutics L.P. (8810), Adlon Therapeutics L.P. (6745), Greenfield BioVentures L.P. (6150), Seven Seas Hill Corp.
(4591), Ophir Green Corp. (4594), Purdue Pharma of Puerto Rico (3925), Purdue Products L.P. (4140), Purdue
Pharmaceutical Products L.P. (3902), Purdue Neuroscience Company (4712), Nayatt Cove Lifescience Inc. (7805),
Button Land L.P. (7502), Rhodes Associates L.P. (N/A), Paul Land Inc. (7425), Quidnick Land L.P. (7584), Rhodes
Pharmaceuticals L.P. (6166), Rhodes Technologies (7143), UDF LP (0495), SVC Pharma LP (5717) and SVC Pharma
Inc. (4014). The Debtors’ corporate headquarters is located at One Stamford Forum, 201 Tresser Boulevard, Stamford,
CT 06901.
2 Capitalized terms used but not defined herein have the meanings ascribed to such terms in the Plan or the Disclosure
Statement & Solicitation Procedures Order (as defined herein), as applicable.
89428-12
2
is classified under the Plan in Class 4 (Non-Federal Domestic Governmental Claims). Except as
otherwise set forth in the Bar Date Order, all timely filed Claims have been deemed filed against
the Debtors, and, therefore, you are being solicited to vote to accept or reject the Plan as provided
in Item 2 below on account of your Class 4 Claim.
The rights of Holders of Claims in Class 4 are described in the Disclosure Statement for
the Plan, filed on March 19, 2025 [D.I. 7307] (together with all schedules and exhibits thereto, and
as may be modified, amended or supplemented from time to time, the “Disclosure Statement”) and
the Bankruptcy Court’s order approving the Disclosure Statement and related solicitation
procedures [D.I. 7615] (the “Disclosure Statement & Solicitation Procedures Order”). The
Solicitation Package you are receiving with this Ballot provides instructions detailing how to
access electronic versions, request hard copies or request flash-drive format versions of each of
the Disclosure Statement & Solicitation Procedures Order as entered by the Bankruptcy Court
(without any exhibits), the Disclosure Statement as approved by the Court (with the Plan annexed
thereto) and a letter from the Official Committee of Unsecured Creditors (such letter, the
“Creditors’ Committee Letter”). If you would like to obtain additional solicitation materials, free
of charge, you may contact the Solicitation Agent by (i) visiting the Debtors’ case website at
https://restructuring.ra.kroll.com/purduepharma; (ii) writing Purdue Pharma Ballot Processing, c/o
Kroll Restructuring Administration LLC, 850 3rd Avenue, Suite 412, Brooklyn, NY 11232;
(iii) emailing purduepharmainfo@kroll.com (with “Purdue Pharma Solicitation Inquiry” in the
subject line) or (iv) calling the Solicitation Agent at (844) 217-0912 (U.S./Canada, toll-free) or +1
(347) 859-8093 (if calling from outside the U.S. or Canada). You may also access these materials
for a fee via PACER at https://www.nysb.uscourts.gov/.
Pursuant to the Disclosure Statement & Solicitation Procedures Order, the Bankruptcy
Court has approved the Disclosure Statement as containing adequate information under
section 1125 of the Bankruptcy Code. Bankruptcy Court approval of the Disclosure Statement
does not indicate approval of the Plan by the Bankruptcy Court. This Ballot may not be used for
any purpose other than to vote to accept or reject the Plan. If you believe that you have received
this Ballot in error, please contact the Solicitation Agent at the address or telephone numbers set
forth above.
For your vote to be counted, this Ballot must be properly completed, signed and
returned to the Solicitation Agent so that it is actually received by the Solicitation Agent no
later than 4:00 p.m. (prevailing Eastern Time) on September 30, 2025.
If a controversy arises regarding whether any Claim is properly classified under the Plan,
the Bankruptcy Court shall, upon proper motion and notice, determine such controversy at the
Confirmation Hearing. If the Bankruptcy Court finds that the classification of any Claim is
improper, then such Claim shall be reclassified and the Ballot previously cast by the Holder of
such Claim shall be counted in, and the Claim shall receive the treatment prescribed in, the Class
in which the Bankruptcy Court determines such Claim should have been classified, without the
necessity of resoliciting any votes on the Plan. Notwithstanding the fact that your Claim would
otherwise satisfy the definition of another type of Claim, or your receipt of a ballot or notice, which
identifies your Claim as belonging to a specific Class for voting and distribution purposes, any
Claim that satisfies the definition of Co-Defendant Claims under Sections 1.1 and 4.17 of the Plan
89428-12
3
shall be a Co-Defendant Claim and any Claim that satisfies the definition of an Other Subordinated
Claim under Sections 1.1 and 4.18 of the Plan shall be an Other Subordinated Claim.
If you have any questions on how to properly complete this Ballot, please contact the Solicitation
Agent at (844) 217-0912 (U.S./Canada, toll-free) or +1 (347) 859-8093 (international) or by
email at purduepharmainfo@kroll.com (with “Purdue Pharma Solicitation Inquiry” in the subject
line). You may also contact the Creditors’ Committee with any questions at
PurdueCreditorInfo@AkinGump.com. THE SOLICITATION AGENT AND THE
CREDITORS’ COMMITTEE ARE NOT AUTHORIZED TO, AND WILL NOT,
PROVIDE YOU WITH LEGAL ADVICE.
89428-12
4
IMPORTANT NOTICE REGARDING CERTAIN RELEASES (INCLUDING THIRD-PARTY
RELEASES), EXCULPATION, INJUNCTION AND CHANNELING INJUNCTION
PROVISIONS IN THE PLAN:
Sections 10.6, 10.7, 10.8, 10.9, 10.10, 10.11, 10.12 and 10.13 of the Plan contain release, shareholder
release, exculpation, injunction, channeling injunction, MDT Insurer injunction, Settling MDT Insurer
injunction and shareholder channeling injunction provisions. Thus, you are advised to review and
consider the Plan, the Disclosure Statement and the Creditors’ Committee Letter carefully. Below is
a summary of the release provisions. For the avoidance of doubt, to the extent any provision of this
notice conflicts with the terms of the Plan, the terms of the Plan will control. Capitalized terms used
below have the meanings ascribed to such terms in the Plan.
Pursuant to the Plan, certain Releasing Parties are releasing (i) the Released Parties and (ii) the
Shareholder Released Parties from certain Claims and Causes of Action.
The Releasing Parties include, collectively, (i) the Supporting Claimants, solely in their respective
capacities as such, (ii) the Opt-In Settling Creditors, (iii) the Settling Co-Defendants and (iv) with
respect to each of the Persons in the foregoing clauses (i) through (iii), each of their Related Parties to
the extent such Releasing Party has the authority under applicable law to grant such release on their
behalf, in each case, other than any Shareholder Released Party.
The Released Parties include, collectively, (i) the Debtors, (ii) each of the Debtors’ Related Parties,
solely in their respective capacities as such, and (iii) solely for purposes of the releases by the Debtors
in Section 10.6(a) of the Plan, (A) the Supporting Claimants, the Creditors’ Committee and the
Creditors’ Committee’s members and each of their respective professionals, in each case solely in their
respective capacities as such and (B) the Settling Co-Defendants and each of their Related Parties, in
each case solely in their respective capacities as such; provided, however, that, notwithstanding the
foregoing or anything herein to the contrary, no Excluded Party or Shareholder Release Snapback Party
shall be a Released Party in any capacity or respect. For purposes of this definition of “Released
Parties,” the phrase “solely in their respective capacities as such” means, with respect to a Person,
solely to the extent a claim against such Person (x) arises from such Person’s conduct or actions taken
in such capacity, or from such Person’s identified capacity in relation to another specified Released
Party and not, in either case, from such Person’s conduct or actions independent of such capacity, and
(y) to the extent such Person’s liability depends on or derives from the liability of such other Released
Party, such claim would be released if asserted against such other Released Party.
The Shareholder Released Parties include the beneficiaries of the separate shareholder release
provisions in the Plan. The Plan Supplement will include the Shareholder Settlement, which will
provide for, among other things, the settlement of claims against the Shareholder Released Parties.
Your participation in the Third-Party Releases will be governed by the terms of the
Governmental Entity Shareholder Direct Settlement.
You are advised to carefully review the Plan, the Disclosure Statement, the Plan Supplement and
the Governmental Remediation Trust Documents, which set forth the eligibility requirements
and process by which the Governmental Remediation Trust will make payments to Holders of
qualified Non-Federal Domestic Governmental Claims. For the avoidance of doubt, to the extent
any provision of this notice conflicts with the terms of the Plan, the terms of the Plan will control.
89428-12
5
INSTRUCTIONS FOR COMPLETING THIS BALLOT
This Ballot is provided to you to solicit your vote to accept or reject the Plan. The terms
of the Plan are described in the Disclosure Statement. PLEASE READ THE PLAN AND THE
DISCLOSURE STATEMENT CAREFULLY BEFORE COMPLETING THIS BALLOT.
The Plan will be accepted by Class 4 if the Plan is accepted by the Holders of at least two-
thirds (2/3) in amount and at least one-half (1/2) in number of the Claims in Class 4 that vote on
the Plan in such Class. In the event that Class 4 votes to reject the Plan, the Bankruptcy Court may
nevertheless confirm the Plan and, thereby, make the Plan binding on the Holders of Claims in
Class 4 if the Bankruptcy Court finds that the Plan does not unfairly discriminate against, and
accords fair and equitable treatment to, the Holders of Claims in Class 4 and otherwise satisfies
the requirements of section 1129(b) of the Bankruptcy Code. If the Plan is confirmed by the
Bankruptcy Court, all Holders of Claims against, and Interests in, the Debtors (including those
Holders who abstain from voting on or vote to reject the confirmed Plan, and those Holders who
are not entitled to vote on the confirmed Plan) will be bound by the confirmed Plan and the
transactions contemplated thereunder.
To have your vote counted, you must complete, sign and return this Ballot so that it
is actually received by the Solicitation Agent no later than the Voting Deadline of September
30, 2025 at 4:00 p.m. (prevailing Eastern Time). Ballots must be delivered to the Solicitation
Agent at the appropriate address listed below:
If online by E-Ballot: If by standard or overnight mail: If by hand delivery:
Visit https://restructuring.ra.kroll.com
/purduepharma and click on the
“Submit E-Ballot” link.
Purdue Pharma Ballot Processing
c/o Kroll Restructuring
Administration LLC
850 3rd Avenue, Suite 412
Brooklyn, NY 11232
For your E-Ballot login credentials and
further details, please see page 8
below.
Purdue Pharma Ballot Processing
c/o Kroll Restructuring Administration
LLC
850 3rd Avenue, Suite 412
Brooklyn, NY 11232
If you plan to hand-deliver your Ballot
to Kroll’s office, please email
purduepharmaballots@kroll.com
(with “Purdue Pharma Ballot
Delivery” in the subject line) at least
twenty-four (24) hours in advance of
your arrival at the Kroll address above
to arrange delivery.
Class 4 Ballots will not be accepted by telecopy, facsimile, email or other electronic
means of transmission (other than by E-Ballot).
You must properly complete the Ballot as follows:
a.Item 1 (Amount of Claim). Please note that each Claim in Class 4 has been
allowed in the amount of $1.00 for voting purposes only, and not for
distribution, allowance or any other purpose.
89428-12
6
b. Item 2 (Vote on the Plan). Cast one vote to accept or reject the Plan by checking
the appropriate box in Item 2 below. You must vote the entire amount of your Claim
either to accept (i.e., vote in favor of) or reject (i.e., vote against) the Plan and you
may not split your vote. Accordingly, any vote within a single Class that attempts
partially to accept and partially reject the Plan will not be counted.
c. If you hold Claims in a Class other than Class 4, you may receive more than one
Ballot or Solicitation Package, labeled for a different Class of Claims. Your vote
will be counted in determining acceptance or rejection of the Plan by a particular
Class of Claims only if you complete, sign and return the Ballot labeled for such
Class of Claims in accordance with the instructions on that Ballot.
d. If more than one timely, properly completed Ballot is received, unless the Holder
of the Class 4 Claim receives Bankruptcy Court approval otherwise, then the last
properly executed, timely received, valid Ballot will be deemed to reflect that
voter’s intent and will supersede and revoke any prior Ballot.
e. If you fail to designate either an acceptance or rejection of the Plan or designate
both an acceptance and rejection of the Plan, the Solicitation Agent may, in its
discretion, either contact you to attempt to cure the defect or not count your vote as
either an acceptance or rejection of the Plan.
f. Item 3 (Acknowledgments and Certifications). Item 3 contains certain required
certifications, which you are making by signing and returning the Ballot. Please
ensure that you have read and understood the certifications prior to signing the
Ballot and the certifications are correct for your Ballot. Provide your name, mailing
address and any remaining information requested in Item 3 below.
g. If you are completing this Ballot on behalf of another claimant, indicate your
relationship with such claimant and the capacity in which you are signing on the
appropriate line in Item 3 in the Ballot below. By submitting the Ballot, you are
certifying that you have authority to so act and agree to provide documents
evidencing such authority upon request (e.g., a power of attorney or a certified copy
of board resolutions authorizing you to so act).
h. Sign and date the Ballot.
i. If additional space is required to respond to any item on the Ballot, please use
additional sheets of paper clearly marked to indicate the applicable item of the
Ballot to which you are responding. Do not include medical records with this
Ballot. Medical records cannot be returned by the Solicitation Agent.
j. Deliver the completed, executed Ballot so as to be actually received by the
Solicitation Agent by the Voting Deadline.
89428-12
7
PLEASE NOTE:
No Ballot shall constitute or be deemed a Proof of Claim or an assertion of a Claim. No
fees, commissions, or other remuneration will be payable for soliciting votes on the Plan.
NOTHING CONTAINED HEREIN OR IN THE SOLICITATION PACKAGES
SHALL RENDER YOU OR ANY OTHER PERSON THE AGENT OF THE DEBTORS OR
THE SOLICITATION AGENT, OR AUTHORIZE YOU OR ANY OTHER PERSON TO
USE ANY DOCUMENT OR MAKE ANY STATEMENTS ON BEHALF OF THE
DEBTORS OR THE SOLICITATION AGENT WITH RESPECT TO THE PLAN,
EXCEPT FOR THE STATEMENTS CONTAINED IN THE SOLICITATION
PACKAGES.
IF THE DEBTORS’ PLAN OF REORGANIZATION IS CONFIRMED BY THE
BANKRUPTCY COURT, IT WILL BE BINDING ON YOU WHETHER OR NOT YOU
HAVE VOTED TO ACCEPT OR REJECT THE DEBTORS’ PLAN OF
REORGANIZATION (EXCEPT AS OTHERWISE PROVIDED IN THE PLAN).
IF YOU (A) HAVE ANY QUESTIONS REGARDING THE BALLOT, (B) DID NOT
RECEIVE A RETURN ENVELOPE WITH YOUR BALLOT, OR (C) NEED
ADDITIONAL COPIES OF THE BALLOT OR OTHER ENCLOSED MATERIALS,
PLEASE CONTACT THE SOLICITATION AGENT AT 844-217-0912 (U.S./CANADA,
TOLL-FREE) OR +1 347-859-8093 (INTERNATIONAL), OR BY
EMAILING PURDUEPHARMAINFO@KROLL.COM (WITH “PURDUE
PHARMA SOLICITATION INQUIRY” IN THE SUBJECT LINE). PLEASE DO NOT
DIRECT ANY INQUIRIES TO THE BANKRUPTCY COURT. YOU MAY ALSO
CONTACT THE CREDITORS’ COMMITTEE WITH ANY
QUESTIONS AT PURDUECREDITORINFO@AKINGUMP.COM. THE
SOLICITATION AGENT AND THE CREDITORS’ COMMITTEE ARE NOT
AUTHORIZED TO, AND WILL NOT, PROVIDE YOU WITH LEGAL ADVICE.
89428-12
8
SUBMITTING BY E-BALLOT
PLEASE COMPLETE THE FOLLOWING:
To submit your Ballot via the “E-Ballot” platform, please visit
https://restructuring.ra.kroll.com/purduepharma. Click on the “Submit E-Ballot” section
of the website and follow the instructions to submit your Ballot.
IMPORTANT NOTE: You will need the following information to retrieve and submit your
customized E-Ballot:
Unique E-Ballot ID#:_________________________________________
The Solicitation Agent’s “E-Ballot” platform is the sole manner in which your Ballot will be
accepted via electronic or online transmission. Ballots submitted by telecopy, facsimile,
email or other electronic means of transmission will not be counted.
Each E-Ballot ID# is to be used solely for voting only those Claims described in Item 1 of
your E-Ballot. Please complete and submit an E-Ballot for each E-Ballot ID# you receive, as
applicable.
Holders who cast a Ballot using the Solicitation Agent’s “E-Ballot” platform should NOT also
submit a paper Ballot.
89428-12
Voter ID #
43161
9
CLASS 4 BALLOT
PLEASE COMPLETE THE FOLLOWING:
Item 1. Amount of Class 4 Claims. Please note that each Claim in Class 4 has been allowed in
the amount of $1.00 for voting purposes only, and not for purposes of ultimate “Allowance” of a
Claim, distribution of value under the Plan or for any other purpose. For the avoidance of doubt,
the $1.00 amount at which a Claim has been allowed for voting purposes does not impact the
payment that a Holder of a Class 4 Claim may receive.
Claims Amount: $1.00
Item 2. Vote on the Plan. The undersigned Holder of Class 4 Claims hereby votes to (check only
one box):
☐ ACCEPT (I.E., VOTE IN FAVOR OF) the Plan
☐ REJECT (I.E., VOTE AGAINST) the Plan
Item 3. Acknowledgments and Certification. By signing this Ballot, the undersigned certifies
and/or acknowledges that:
(a) either the undersigned is: (i) the Holder of the Class 4 Claims being voted;
or (ii) an authorized signatory for a person or entity that is a Holder of the
Class 4 Claims being voted, and, in either case, has the full power and
authority to vote to accept or reject the Plan with respect to the Claims
identified in Item 1 above;
(b) the undersigned has been provided with a copy of the Disclosure Statement,
including the Plan and all other exhibits thereto, the Disclosure Statement
& Solicitation Procedures Order without exhibits and a Confirmation
Hearing Notice;
(c) the solicitation of votes is subject to all terms and conditions set forth in the
Plan, Disclosure Statement & Solicitation Procedures Order and the
procedures for the solicitation of votes to accept or reject the Plan contained
therein;
(d) the undersigned has cast the same vote with respect to all of its Class 4
Claims; and
(e) no other Ballots with respect to the amount of the Class 4 Claims identified
in Item 1 above have been cast or, if any other Ballots have been cast with
respect to such Claims, then any such earlier Ballots are hereby revoked.
89428-12
4
10
Name of Claimant:
Signature:
Name of Signatory
(if different than Claimant):
If authorized by Agent, Title of Agent:
Street Address:
Street Address:
(continued)
City, State, Zip Code:
Telephone Number:
Email Address:
Date Completed:
89428-12
08/28/2025
City of Sanger Texas
John C. Noblitt
citymanager@sangertexas.org
9402229970
502 Elm Street
City Manager
Sanger
Eballot Confirmation:
EBallot Electronically Submitted on (UTC) :
Submitted by:
2025-08-28T16:29:58.911Z
citymanager@sangertexas.org
City of Sanger Texas
2325-2-VBQMS-684700547